InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Plooster Matthew R, Director. Insider active across 2 companies, notably Kempharm, INC. Aggregated, 5 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €47k. Activity tracked since 1 December 2021. The latest transaction was filed on 9 March 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Matthew R. Plooster is a Director at KEMPHARM, INC. In this role, he participates in the governance and strategy of the company. His experience is valuable for the development of KEMPHARM.